BREAST CARCINOMA IN SITU

Clinical trials for BREAST CARCINOMA IN SITU explained in plain language.

Never miss a new study

Get alerted when new BREAST CARCINOMA IN SITU trials appear

Sign up with your email to follow new studies for BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 2

New combo therapy aims to shrink tumors, save breasts

Disease control ENROLLING_BY_INVITATION

This study is testing whether a combination of two drugs (trastuzumab and a taxane chemotherapy) given before surgery can effectively shrink tumors in people with a specific type of early breast cancer (HER2-positive). The main goal is to see if this approach allows more patients…

Matched conditions: BREAST CARCINOMA IN SITU

Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated Mar 17, 2026 13:10 UTC

BREAST CARCINOMA IN SITU

Get alerted when new BREAST CARCINOMA IN SITU trials appear

New combo therapy aims to shrink tumors, save breasts